Vicor shares followed a similar upward trajectory, gaining 11% to reach $204 after the company granted a new license to an original equipment manufacturer. The momentum shifted abruptly for other firms, however. Longeveron saw its valuation collapse, with shares sinking 60% to $2.69 after announcing that a pediatric heart condition trial failed to meet its primary clinical endpoint.
In section Market Quotes
Market Movers: Generac Soars as Longeveron Plummets
A $2.4 billion agreement to supply data-center generators to Amazon sent Generac shares climbing 35% to $237 in Wednesday’s after-hours trading. This massive surge highlights a volatile session for investors, as other market players experienced sharp swings following new licensing deals, failed clinical trials, and public stock offerings.
Viant Technology also faced downward pressure following the announcement of an underwritten public offering. The company confirmed that a significant stockholder plans to offload 8.5 million shares, a move that triggered a 10% decline, leaving the stock at $11.10.
Comments (0)
No comments yet. Be the first!